Search research articles
Contact Us
Filters
Showing results (1271-1280 of 1,421) with videos related to
Page
of 143
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2020
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
Raffit Hassan, George R Blumenschein, Kathleen N Moore, et al.
Biomaterials
|
May 17, 2016
Treatment of hind limb ischemia using angiogenic peptide nanofibers
Vivek A Kumar, Qi Liu, Navindee C Wickremasinghe, et al.
American Journal of Obstetrics and Gynecology
|
October 18, 2017
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
Erin A Bishop, James J Java, Kathleen N Moore, et al.
Clinical Reviews in Bone and Mineral Metabolism
|
April 2, 2019
Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications
Courtney E Baker, Stephanie N Moore-Lotridge, Alexander A Hysong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 23, 2021
Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis
Norihisa Nishimura, Davide De Battista, David R McGivern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.
Science Immunology
|
January 6, 2023
Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis
Karen Laky, Jessica L Kinard, Jenny Min Li, et al.
Journal of the National Cancer Institute
|
March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates
Laura Pala, Federico Merlo, Isabella Sala, et al.
Gynecologic Oncology
|
April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
Transplantation
|
January 6, 2026
Adjuvant IL-15 Blockade Significantly Improves Survival in a CD28-based Immunosuppression Protocol of Pig-to-nonhuman Primate Renal Xenotransplantation
James A Keiler, Jakob G Habib, Ji W Han, et al.
Page
of 143
Search research articles
Search
Showing results (1271-1280 of 1,421) with videos related to
Sort By:
Page
of 143
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2020
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
Raffit Hassan, George R Blumenschein, Kathleen N Moore, et al.
Biomaterials
|
May 17, 2016
Treatment of hind limb ischemia using angiogenic peptide nanofibers
Vivek A Kumar, Qi Liu, Navindee C Wickremasinghe, et al.
American Journal of Obstetrics and Gynecology
|
October 18, 2017
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
Erin A Bishop, James J Java, Kathleen N Moore, et al.
Clinical Reviews in Bone and Mineral Metabolism
|
April 2, 2019
Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications
Courtney E Baker, Stephanie N Moore-Lotridge, Alexander A Hysong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 23, 2021
Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis
Norihisa Nishimura, Davide De Battista, David R McGivern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.
Science Immunology
|
January 6, 2023
Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis
Karen Laky, Jessica L Kinard, Jenny Min Li, et al.
Journal of the National Cancer Institute
|
March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates
Laura Pala, Federico Merlo, Isabella Sala, et al.
Gynecologic Oncology
|
April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
Transplantation
|
January 6, 2026
Adjuvant IL-15 Blockade Significantly Improves Survival in a CD28-based Immunosuppression Protocol of Pig-to-nonhuman Primate Renal Xenotransplantation
James A Keiler, Jakob G Habib, Ji W Han, et al.
Page
of 143